She will appear at the beginning of the schedule as part of a discussion titled, “What’s Next: Targeting Pancreatic Cancer,” which starts at 1 p.m. ET, 10 a.m. PT. The latest in pancreatic cancer research and treatment will be explored.
The public is invited to register and attend at no charge.
Fleshman will share how pancreatic cancer research has changed over the past 20 years, since PanCAN’s founding, and what progress has been made in the field.
She will also answer questions related to PanCAN’s Precision PromiseSM clinical trial platform that is now enrolling eligible patients, as well as the latest in progress toward an early detection method.
The Atlantic’s People v. Cancer series has been called “relevant and thought-provoking” over the years.
Other featured guests this year, in addition to Fleshman, include:
- National Cancer Institute Director Ned Sharpless
- Stand Up To Cancer CEO Sung Poblete
- ABC News Co-anchor Amy Robach
- Actor and cancer survivor Fran Drescher
As part of the Nov. 18 People v. Cancer series, The Atlantic will also discuss cancer and COVID, mental health and battling cancer, and many other topics.